Moleculebiological analysis of HLA class II in autoimmune hepatitis.

自身免疫性肝炎HLA II类的分子生物学分析。

基本信息

  • 批准号:
    03454227
  • 负责人:
  • 金额:
    $ 4.03万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 财政年份:
    1991
  • 资助国家:
    日本
  • 起止时间:
    1991 至 1993
  • 项目状态:
    已结题

项目摘要

1. To investigate the association between autoimmune hepatitis and HLA alleles in Japanese patients, serological typing and class II genotyping were performed using the polymerase chain reaction-restriction fragment length polymorphisms(PCR-RFLP)method. Serologicaltyping showed that HLA-B54, -Dr53, and -DQ4 were significantly associated with autoimmune hepatitis (88.7%). In PCR-RFLP typing, the frequency of Dw between the patients and thecontrols who were DR4-positive. The significant increase observed in DQA1**0301 and DQB1**0401 was explained by a linkage disequilibrium with DR4. Six DR4-negative patients had DR2, but there was no significant difference in the frequency of the DR2-positive controls. No DQB1 allele was significantly associated with autoimmune hepatitis. These findings suggest that the basic amino acid at position 13, which is present only on the DR4 B1 molecules (Arg on DR2 and His on DR4), contributes to the susceptibility to autoimmune hepatitis among the Japanese.2 … More . We clarified the clinical and immunogenetical differences between patients with autoimmune hepatitis (AI-CAH), and patients with type C chronic active hepatitis(C-CAH) and type B chronic active hepatitis (B-CAH) who were positive for autoantibodies and hyperglobulinemia. While histories of blood transfusion, intravenous drug abuse and tattoo were seen frequently in patients with type C-CAH, they were rare in patients with AI-CAH.The severe subjective symptoms including anorexia, lethargy, icterus, high fever and extrahepatic manifestations, and severe abnormality of biochemical data were seen in AI-CAH.HLA-DR4 was the most frequently associated with AI-CAH(89%) and 6 DR4-negative patients were positive for DR2. HLA-DNA typing showed that there was no significant difference in the frequency of DR4-associated Dw-alleles between the patients and controls who were positive for DR4. These findings suggest that the basic amino acid at position 13, which is present only DR2 and DR4-B1 molecules, may contribute to the susceptibility to autoimmune hepatitis of Japanese. Thus, we conclude that AI-CAH is a genetically restricted disease and different from C-CAH which is a viral infectious disease. Less
1.为了研究日本患者自身免疫性肝炎与HLA等位基因之间的相关性,采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法进行血清学分型和II类基因分型。血清学分型结果显示,HLA-B54、-Dr 53和-DQ 4与自身免疫性肝炎显著相关(88.7%)。在PCR-RFLP分型中,DR 4阳性者与对照者之间Dw的频率差异有统计学意义(P < 0. 05)。在DQA 1 **0301和DQB 1 **0401中观察到的显著增加由与DR 4的连锁不平衡解释。6名DR 4阴性患者有DR 2,但DR 2阳性对照的频率无显著差异。DQB 1等位基因与自身免疫性肝炎无显著相关性。这些发现表明,仅存在于DR 4 B1分子上的13位碱性氨基酸(DR 2上的Arg和DR 4上的His)导致了日本人对自身免疫性肝炎的易感性。 ...更多信息 .我们阐明了自身免疫性肝炎(AI-CAH)患者与自身抗体和高球蛋白血症阳性的C型慢性活动性肝炎(C-CAH)和B型慢性活动性肝炎(B-CAH)患者之间的临床和免疫遗传学差异。C-CAH患者输血史、静脉吸毒史、纹身史多见,AI-CAH患者较少见,自觉症状严重,主要表现为厌食、嗜睡、黄疸、高热、肝外表现等。AI-CAH的HLA-DR 4与AI-CAH的相关性最高(89%),DR 4 - 6与AI-CAH的相关性最高(80%),阴性患者DR 2阳性。HLA-DNA分型结果显示,DR 4阳性的患者与对照组之间DR 4相关Dw等位基因频率无显著差异。这些结果表明,在位置13的碱性氨基酸,这是目前只有DR 2和DR 4-B1分子,可能有助于对自身免疫性肝炎的易感性,日本。因此,我们认为AI-CAH是一种遗传限制性疾病,与C-CAH不同,C-CAH是一种病毒感染性疾病。少

项目成果

期刊论文数量(56)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
猪子 英俊: "PCR法を用いたHLAと疾患感受性の解析" 臨床科学. 27. 1063-1069 (1991)
Hidetoshi Inoko:“利用 PCR 方法分析 HLA 和疾病易感性”《临床科学》27. 1063-1069 (1991)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
太田 正穂: "PCRを用いたHLAタイピングによる疾患感受性の解析" 信州医誌. 40. 553-565 (1992)
Masaho Ota:“使用 PCR 进行 HLA 分型分析疾病易感性” Shinshu Medical Journal 40. 553-565 (1992)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T SEKI,et al,: "HLA class 2 molecules and antoimmune hepatitis susceptibility in Japanese patients." Gastroenterology. 103. 1041-1047 (1992)
T SEKI 等人:“日本患者的 HLA 2 类分子和抗免疫性肝炎易感性。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
関 健 他: "最新内科学大系 HLA遺伝子の構造と機能" 中山書店,
Ken Seki等:“HLA基因的最新内科结构和功能”中山书店,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
関 健 他2名: "最新内科学体系:〔免疫系と自己免疫疾患〕III HLA遺伝子の構造と機能" 中山書店,
Ken Seki等2人:《最新的内科系统:[免疫系统和自身免疫性疾病] III HLA基因的结构和功能》中山书店,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KIYOSAWA Kendo其他文献

KIYOSAWA Kendo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KIYOSAWA Kendo', 18)}}的其他基金

The role of hepatitis C infection and proliferators-activated receptor alpha protects (PPA α) in occurrence of hepatocellular carcinoma
丙型肝炎感染和增殖物激活受体α保护(PPAα)在肝细胞癌发生中的作用
  • 批准号:
    15590633
  • 财政年份:
    2003
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular biological significance of asialoglycoprotein receptor in autoimmune hepatitis type I
自身免疫性I型肝炎脱唾液酸糖蛋白受体的分子生物学意义
  • 批准号:
    06454261
  • 财政年份:
    1994
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The Study on anti-PCNA antibody in patient with hepatocellular carcinoma.
肝细胞癌患者抗PCNA抗体的研究。
  • 批准号:
    61570334
  • 财政年份:
    1986
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

HLA class II拘束性T細胞エピトープとなりうる乳癌のpublic neoantigenの探索
寻找乳腺癌中可作为 HLA II 类限制性 T 细胞表位的公共新抗原
  • 批准号:
    24K11737
  • 财政年份:
    2024
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of Conformer-Specific Anti-HLA Class II mAbs
构建体特异性抗 HLA II 类单克隆抗体的开发
  • 批准号:
    10330612
  • 财政年份:
    2021
  • 资助金额:
    $ 4.03万
  • 项目类别:
乳がんのネオアンチゲンにおけるHLA Class II拘束性ペプチドの網羅的探索
乳腺癌新抗原中HLA II类限制性肽的全面搜索
  • 批准号:
    21K08614
  • 财政年份:
    2021
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study to clarify the pathophysiology of childhood nephrotic syndrome and HLA class II
阐明儿童肾病综合征和 HLA II 类病理生理学的研究
  • 批准号:
    20K16892
  • 财政年份:
    2020
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Analysis of HLA-class II expression and regulation mechanism involved in immune editing of liver cancer microenvironment.
肝癌微环境免疫编辑中HLA-II类表达及调控机制分析
  • 批准号:
    19K08464
  • 财政年份:
    2019
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
DBY/HLA class II complex formation on the vascular endothelium leads to cGVHD in female-to-male HSCT
血管内皮上 DBY/HLA II 类复合物的形成导致女性至男性 HSCT 中的 cGVHD
  • 批准号:
    19K17841
  • 财政年份:
    2019
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Studies on narcolepsy by orexin/HLA class II complex
食欲素/HLA II 类复合物对发作性睡病的研究
  • 批准号:
    18K19450
  • 财政年份:
    2018
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Prevention of HBV recurrence by HBV vaccination based on SNP and allele of HLA class II
基于SNP和HLA II类等位基因的乙型肝炎疫苗接种预防乙型肝炎复发
  • 批准号:
    18K08542
  • 财政年份:
    2018
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of CAR-T cells targeting WT1 peptide presented by HLA class II molecules
开发针对HLA II类分子呈递的WT1肽的CAR-T细胞
  • 批准号:
    406751
  • 财政年份:
    2018
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Studentship Programs
Pathogenesis of Chronic Skin Ulcers by anti-HLA Class II/Misfolded Protein Complex Antibodies
抗 HLA II 类/错误折叠蛋白复合物抗体对慢性皮肤溃疡的发病机制
  • 批准号:
    18K08296
  • 财政年份:
    2018
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了